+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 65Years
All Genders
Healthy Volunteers
ID07595263

Study of Ulonivirines Effect on Methadone Levels in Healthy Volunteers Taking Methadone

Led by Merck Sharp & Dohme LLC · Updated on 2026-09-23

14

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating how ulonivirine MK-8507 affects the way methadone is processed in the body. This study involves healthy volunteers who are already participating in a methadone maintenance program. The purpose is to understand if taking ulonivirine with methadone changes the levels or activity of methadone in the body. Participants will take a stable oral dose of methadone daily from 14 days before the study starts through Day 16. On Day 2, participants will receive a single oral dose of ulonivirine together with methadone. The study observes the effects of this combination over this period to assess how ulonivirine impacts methadones presence in the body. During the study, participants will be monitored for up to 24 hours after dosing to measure methadone levels in the blood. Researchers will track various measures such as the amount of methadone in the plasma over time, peak concentrations, and time to peak concentration. Safety is also monitored by recording any adverse events during the 16-day study period. Participants will be required to attend study visits for dosing and assessments during this time.

CONDITIONS

Brief Title

A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)

Research Team

T

Toll Free Number

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here